The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CE activity:

• Don Bradley, MD, MHS-CL
• Edward Buckley, MD
• Frank DeMarco, MSN, RN
• Karen Frush, MD
• Karol Harshaw-Ellis, MSN, DNP 
• Ross McKinney, Jr., MD
• Diana B. McNeill, MD
• Yael Melamede
• Colin O’Leary, MD
• Rebecca Ortega, MHA
• Tom A. Owens, MD
• Philip Rosoff, MD, MA  
• Kevin A. Schulman, MD, MBA
• Megan C. Turner, MD, MHS
• Damon S. Tweedy, MD
• Michael “Buz” Waitzkin, JD

The following speakers and/or planning committee members have indicated that they have the following relationship(s) with industry to disclose:

• Dan Ariely, PhD – Novartis: Speaker.
• Allan D. Kirk, MD, PHD – Bristol-Myers Squibb: Principal Investigator; MedBlue Data: Stockholder, Other; MedBlue Incubator: Other; Semma Therapeutics: Stockholder.
• Adrienne Lloyd, MHA, FACHE – Medical Group Management Association: Speaker, Consultant.
• Manesh R. Patel, MD – AstraZeneca: Principal Investigator, Advisory Board; Bayer: Principal Investigator, Advisory Board; Heartflow: Principal Investigator, Consultant; Janssen: Principal Investigator, Advisory Board; Mytonomy, Advisory Board; Procyrion, Principal Investigator, Advisory Board.
• William J. Richardson, MD – Pfizer, Consultant; Brain Lab, Speaker; Spine Wave, Other.
• Tracy Y. Wang, MD, MHS, MSC – AstraZeneca: Principal Investigator, Consultant; Bristol-Myers Squibb: Principal Investigator; CryoLife: Principal Investigator, Consultant; Chiesi: Principal Investigator; Merck: Principal Investigator; Portola: Principal Investigator; Regeneron: Principal Investigator; Sanofi: Consultant.
• Kevin P. Weinfurt, PhD – U.S. Food and Drug Administration, Employee.
• S. Yousuf Zafar, MD, MHS – AstraZeneca: Other; AIM Specialty Health: Advisory Board; Vivor, LLC: Advisory Board; SamFund: Advisory Board; Shattuck Labs (spouse): Employee, Stock Holder.